Back to the Hive: DOJ Revisits FDCA Charges in Trade Fraud Enforcement

March 9, 2026

Reading Time : 3 min

On February 23, 2026, Cody Matthew Herche, the head of the Department of Justice’s (DOJ) Trade Fraud Task Force created six months ago, announced that the U.S. Attorney’s Office for the Northern District of Illinois will serve as a “leading prosecutorial partner” of the Task Force. Shortly after the announcement, the U.S. Attorney’s Office issued a press release, in which U.S. Attorney Andrew Boutros harkened back to a series of customs and antidumping fraud cases he prosecuted as an Assistant U.S. Attorney involving well-known schemes to avoid trade restrictions on the importation of honey. Boutros noted that “those cases provide valuable insight into how the Trade Fraud Task Force will build future criminal prosecutions.” In those cases, the government charged violations of 18 U.S.C. § 542 (entry of goods by means of false statements) and 18 U.S.C. § 545 (smuggling goods into the United States), as well as violations of the Federal Food, Drug and Cosmetic Act (FDCA), alleging that the imported honey was “adulterated” because it contained an unsafe food additive. It is no surprise that Mr. Boutros will be a lead prosecutorial partner because the counterpart enforcement agencies responsible for trade fraud and enforcement investigations in the Northern District of Illinois, e.g., U.S. Customs and Border Protection (CBP) and Homeland Security Investigations (HSI), are some of the most aggressive in the United States.

In a more recent example—November 2025, Able Groupe, a European company, pled guilty to two felony counts, including one violation of the FDCA for failing to provide prior notice to the Food and Drug Administration (FDA) when importing infant formula into the United States.1 At the time of the illegal importations, several of the infant formulas Able Groupe sold were listed on FDA Import Alerts, a public website and alert system managed by the FDA, due to the formulas’ failure to meet nutrient or labelling requirements. In pleading guilty, Able Groupe admitted that it intended to defraud or mislead in failing to notify the FDA of these imports.

Shortly after this settlement, DOJ’s Criminal Fraud Section created a new unit—the Health & Safety Unit—that will focus on adulterated, misbranded, or counterfeit food, drugs, and devices, among other issues.2 This unit will likely partner with U.S. Attorney’s Offices, including the Northern District of Illinois, as well as CBP and HSI, to prosecute these issues.

Against this backdrop, in addition to other allegations like duty evasion, we expect increased focus and scrutiny in the food space as DOJ and FDA enforcement priorities continue to align. As the administration rolls out and implements several high‑priority initiatives under its “Make America Healthy Again” agenda—including potential reforms to the Generally Recognized as Safe framework, which governs how and which ingredients are permitted for use in food—regulators are signaling heightened attention to food ingredients and supply‑chain integrity.

Key Takeaway: Given DOJ’s creation of the Health & Safety Unit within Criminal Fraud, the FDA’s increased scrutiny of food ingredients, and Boutros’ use of his past prosecutions as a model in serving as a leading prosecutorial partner in the Trade Fraud Task Force, it appears FDCA prosecutions associated with trade issues may be on the rise. Akin will be closely monitoring this space moving forward.

To learn more about the early impact and future direction of the Trade Fraud Task Force, click here to register for Akin’s webinar, “Six Months In: Key Milestones, Trends and What Lies Ahead for the Trade Fraud Task Force,” on March 17, 2026.


1 https://www.justice.gov/opa/pr/online-seller-infant-formula-pleads-guilty-smuggling-and-violating-fda-prior-notice.

2 https://www.justice.gov/criminal/criminal-fraud/health-safety-unit.

Share This Insight

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.